The number of corresponding shares 49,303,063 shares… Transaction volume exceeded 2 million shares
SK Biopharm’s share price is weakening around -8%. From the first trading day of the new year to the end of the six-month mandatory holding period for institutional investors, profit-taking stocks are withdrawn.
According to the Korea Exchange on the 4th, at 11:41 am, SK Biopharm’s stock price is trading at 154,000 won, down 15,000 won (8.88%) from the previous trading day.
The reason for the weakness is the lifting of the six-month mandatory retention period for institutional investors. As the mandatory holding period was released, 49,303,063 shares were released to the market. This amounts to 37.3% of the total volume received by organizations at the time of the competition last year.
The stock price on this day recorded 14,9500 won, a -11.54% drop from the previous day from the market price.
Immediately after the opening, at 10:2 am, stock trading volume was 32,5722, up 3951.98% from the previous day. The cumulative transaction volume so far has also increased 925.89% to more than 2 million.
Han Byeong-hwa, a researcher at Eugene Investment & Securities, said, “SK Biopharm has a higher-than-expected share price increase after listing, so it has a higher evaluation than competitors.”
At the time of the public offering of SK Biopharm, which was listed on July 2nd, the institutions were allocated 13.2 million shares at 49,000 won. The current price is more than three times higher than this.
Copyright © Shin-A Ilbo Unauthorized reproduction and redistribution prohibited